1-5 of 5
Béatrice Turcq
Close
Sort by
Journal Articles

Identification of Imatinib-Sensitizing Genes in Chronic Myeloid Leukemia with a Genome-Scale Crispr Knock-out Screen

Matthieu Lewis, MD, Valerie Prouzet-Mauleon, Elodie Richard, Beatrice Turcq, Richard Iggo, MD PhD, Francois-xavier Mahon, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4233.
https://doi.org/10.1182/blood.V128.22.4233.4233
Published: 2016
Journal Articles

Under-Expression of LINE-1 Retrotransposons in Chronic Myeloid Leukemia Patients: Effect of Tyrosine Kinase Inhibitors

Beatrice Turcq, MD, Marina Josselin, PhD, Kelly Airiau, PhD, Stéphanie Dulucq, PharmD, Gabriel Etienne, MD PhD, Francis Belloc, PhD, Fabienne Hermitte, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5514.
https://doi.org/10.1182/blood.V124.21.5514.5514
Published: 2014
Journal Articles

Defensine Alpha1 as a New Marker of Imatinib Resistance in Chronic Myelogenous Leukemia

Gabriel Etienne, Maryse Dupouy, Claudine Chollet, Jean-Max Pasquet, Eric Lippert, Josy Reiffers, François- Xavier Mahon, Beatrice Turcq
Journal: Blood
Blood (2008) 112 (11): 3180.
https://doi.org/10.1182/blood.V112.11.3180.3180
Published: 2008
Journal Articles

Multidrug resistance gene ( MDR1 ) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Brief Report
Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq, Eric Lippert, Gabriel Etienne, Josy Reiffers, Mathieu Molimard, Maja Krajinovic, François-Xavier Mahon
Journal: Blood
Blood (2008) 112 (5): 2024–2027.
https://doi.org/10.1182/blood-2008-03-147744
Published: 2008
Journal Articles

Generation of Resistance Cell Lines to AMN107, a New Inhibitor of BCR-ABL and Its Effects on Cell Lines Sensitive and Resistant to Imatinib.

Francois-xavier Mahon, MD, PhD, Valerie Lagarde, Paul W. Manley, PhD, Jean-Max Pasquet, PhD, Beatrice Turcq, PhD, Josy Reiffers, MD
Journal: Blood
Blood (2004) 104 (11): 4670.
https://doi.org/10.1182/blood.V104.11.4670.4670
Published: 2004